Modern science has the potential to end the threat of infectious diseases—but the challenge demands a strategic, efficient use of talent and resources, and a global commitment to get it done. It takes a team-approach to discovery and solution application.

OUR MISSION/PURPOSE

Long dedicated to the study of microbial pathogenesis and the treatment and prevention of infectious diseases, Ohio State has recently established the Infectious Diseases Institute to further accelerate a collective capacity for solutions addressing the complexity of infectious diseases. The institute is a direct outgrowth of a decade-long commitment and a multi- million-dollar investment in this area. The institute’s goals are to:

  • Enable discoveries in therapeutics, diagnostics, vaccines, surveillance and tracking.
  • Establish international collaborations, especially with developing countries where emerging and re-emerging infectious diseases often break out.
  • Define the interaction of pathogenic and beneficial microbes in humans, animals, plants and the environment to better understand disease at biological scales ranging from molecular to ecological.
  • Create controls to protect the world’s agricultural stocks and livestock, the food supply, and the environment.
  • Develop new methods to detect outbreaks of infectious diseases and limit their spread.
  • Enhance the infectious diseases teaching and training of our students to prepare the future generation of infectious disease scientists.
  • Engage the community and public policy officials in the on-going efforts to generate solutions to the impact of infectious diseases.

Through a team-based approach we are committed to advancing a comprehensive strategy connecting new knowledge to applications for infectious diseases and improve the implementation and efficacy of solutions in six concentration areas.  

Ohio State will leverage the diversity of its expertise and global reach to create synergy among investigators in the clinical and basic sciences, the social and behavioral sciences, as well as other disciplines, allowing for a holistic approach that simultaneously considers human, agricultural and environmental factors.

Download our handout

Download our brochure

Infectious diseases institute Executive team

MIKE OGLESBEE, DVM, PhD

Director

oglesbee.1@osu.edu | 614-292-4489

JOHN GUNN, PhD

Associate Director

gunn.43@osu.edu | 614-292-6036

MIKE IBBA, PhD

Associate Director

ibba.1@osu.edu | 614-292-2120

TERRY NIBLACK, PhD

Associate Director

niblack.2@osu.edu |

Cathie Smith, PhD, PMP

Chief Operating Officer

smith.4420@osu.edu | 614-292-7437

ROBYN KROEGER

Program Coordinator

kroeger.68@osu.edu | 614-292-3981

KATHY RENICK, MS, CRA

Proposal Development Specialist

renick.9@osu.edu | 614-688-2843

RICK SHAFFER, MA

Business Manager

shaffer.25@osu.edu | 614-633-7210